ID18301A - METHODS FOR PREVENTION OF CELLULAR PROLIFERATION AND RESTENOSIS - Google Patents

METHODS FOR PREVENTION OF CELLULAR PROLIFERATION AND RESTENOSIS

Info

Publication number
ID18301A
ID18301A IDP972912A ID972912A ID18301A ID 18301 A ID18301 A ID 18301A ID P972912 A IDP972912 A ID P972912A ID 972912 A ID972912 A ID 972912A ID 18301 A ID18301 A ID 18301A
Authority
ID
Indonesia
Prior art keywords
restenosis
prevention
methods
cellular proliferation
proliferation
Prior art date
Application number
IDP972912A
Other languages
Indonesian (id)
Inventor
Margaret Forney Prescott
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID18301A publication Critical patent/ID18301A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11013—Protein kinase C (2.7.11.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP972912A 1996-08-20 1997-08-20 METHODS FOR PREVENTION OF CELLULAR PROLIFERATION AND RESTENOSIS ID18301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2421996P 1996-08-20 1996-08-20
US2507296P 1996-08-30 1996-08-30

Publications (1)

Publication Number Publication Date
ID18301A true ID18301A (en) 1998-02-26

Family

ID=26698189

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972912A ID18301A (en) 1996-08-20 1997-08-20 METHODS FOR PREVENTION OF CELLULAR PROLIFERATION AND RESTENOSIS

Country Status (3)

Country Link
AU (1) AU4205597A (en)
ID (1) ID18301A (en)
WO (1) WO1998007415A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190869B1 (en) 1999-10-26 2001-02-20 Isis Pharmaceuticals, Inc. Antisense inhibition of protein kinase C-theta expression
US6641611B2 (en) 2001-11-26 2003-11-04 Swaminathan Jayaraman Therapeutic coating for an intravascular implant
CN1582150B (en) * 2001-10-30 2011-09-07 诺瓦提斯公司 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
DE102004019413A1 (en) * 2004-04-19 2005-11-24 Phenos Gmbh Use of substances (e.g. nucleic acids, proteins and peptides), which restrain/reduce the expression and/or activity of protein kinase C-epsilon for the treatment/prevention of e.g. circulatory and vascular diseases
WO2008033956A2 (en) 2006-09-13 2008-03-20 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
DE3937015A1 (en) * 1988-11-10 1990-05-17 Hoechst Ag USE OF ETHYLENE DIAMETRA ACID ACID AS AN INHIBITOR OF THE CALCIUM / CALMODULIN DEPENDENT PROTEIN KINASE II OR THE PROTEIN KINASE C
US5242397A (en) * 1989-06-20 1993-09-07 Cedars-Sinai Medical Center Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty
EP0541486A1 (en) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclic conjugates
ATE212063T1 (en) * 1992-03-16 2002-02-15 Isis Pharmaceuticals Inc OLIGONUCLEOTIDE MODULATION OF PROTEIN KINASE C
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives

Also Published As

Publication number Publication date
WO1998007415A2 (en) 1998-02-26
WO1998007415A3 (en) 1998-05-07
AU4205597A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
ID27589A (en) BICYCLIC PYYRIMINE AND DIHYDROPIRYMIDINE BICYCLIC 3,4 AS A RESULTS OF MOBILE PROLIFERATION
DE69831755D1 (en) OPTOACUSTIC CONSTANCES AND METHOD OF USE
BR9709811A (en) Composed of indenonaftopiranos and photochromic article
BR9711799A (en) Composed of indenonaphtopyranes and photochromic article
PT946323E (en) POS OF NIOBIO AND CONDENSADORES ELETROLITICOS OF NIOBIO
DE69836299D1 (en) Method and device for checking the field of cellular telephones
DE69835514D1 (en) MICROWAVE ANTENNA SYSTEM AND METHOD
ID18128A (en) METHODS AND EQUIPMENT FOR Aligning PERSONAL RADIO SYSTEMS
EP0971723A4 (en) Compositions and methods for inhibiting cellular proliferation
DE69834401D1 (en) BUSINTERFACESYSTEM AND METHOD
DE69840301D1 (en) METHOD AND SYSTEM FOR THE LOCAL DETERMINATION OF MOBILE OPERATING DEVICES
ID19422A (en) PYRIDINA AND SUBSTITUTED BIFENYL
PL340606A1 (en) Methods of and materials for treating and preventing mucositis
EP1018987A4 (en) Neocartilage and methods of use
MA26668A1 (en) ACTIVATORS OF hPPARy AND hPPARa
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
DE69838230D1 (en) FREQUENCY TRANSFER AND METHOD
PL333434A1 (en) Aminoguanidines and alkoxyguanidines as inhibitors of proteases
ID21332A (en) METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA
DE69717570D1 (en) Tires and form of vulcanization
PT927183E (en) SPIROCYLIC INHIBITORS OF METALOPROTEASES
ID19385A (en) TERMOSETTING ADESIVES AND THE METHOD OF MAKING IT
PL336582A1 (en) Leptin as an inhibitor of neoplastic cell proliferation
ID18456A (en) PRODUCTION-JOINT 6-AMINOCAPRONITRIL AND HEXSAMETYLENADIAMINA
DE19782204T1 (en) Extension facility and procedure